UniProt ID | LATS2_HUMAN | |
---|---|---|
UniProt AC | Q9NRM7 | |
Protein Name | Serine/threonine-protein kinase LATS2 | |
Gene Name | LATS2 {ECO:0000312|EMBL:BAA92381.1} | |
Organism | Homo sapiens (Human). | |
Sequence Length | 1088 | |
Subcellular Localization | Cytoplasm, cytoskeleton, microtubule organizing center, centrosome. Cytoplasm. Cytoplasm, cytoskeleton, spindle pole. Nucleus. Colocalizes with AURKA at the centrosomes during interphase, early prophase and cytokinesis. Migrates to the spindle poles | |
Protein Description | Negative regulator of YAP1 in the Hippo signaling pathway that plays a pivotal role in organ size control and tumor suppression by restricting proliferation and promoting apoptosis. The core of this pathway is composed of a kinase cascade wherein STK3/MST2 and STK4/MST1, in complex with its regulatory protein SAV1, phosphorylates and activates LATS1/2 in complex with its regulatory protein MOB1, which in turn phosphorylates and inactivates YAP1 oncoprotein and WWTR1/TAZ. Phosphorylation of YAP1 by LATS2 inhibits its translocation into the nucleus to regulate cellular genes important for cell proliferation, cell death, and cell migration. Acts as a tumor suppressor which plays a critical role in centrosome duplication, maintenance of mitotic fidelity and genomic stability. Negatively regulates G1/S transition by down-regulating cyclin E/CDK2 kinase activity. Negative regulator of the androgen receptor. Phosphorylates SNAI1 in the nucleus leading to its nuclear retention and stabilization, which enhances its epithelial-mesenchymal transition and tumor cell invasion/migration activities. This tumor-promoting activity is independent of its effects upon YAP1 or WWTR1/TAZ.. | |
Protein Sequence | MRPKTFPATTYSGNSRQRLQEIREGLKQPSKSSVQGLPAGPNSDTSLDAKVLGSKDATRQQQQMRATPKFGPYQKALREIRYSLLPFANESGTSAAAEVNRQMLQELVNAGCDQEMAGRALKQTGSRSIEAALEYISKMGYLDPRNEQIVRVIKQTSPGKGLMPTPVTRRPSFEGTGDSFASYHQLSGTPYEGPSFGADGPTALEEMPRPYVDYLFPGVGPHGPGHQHQHPPKGYGASVEAAGAHFPLQGAHYGRPHLLVPGEPLGYGVQRSPSFQSKTPPETGGYASLPTKGQGGPPGAGLAFPPPAAGLYVPHPHHKQAGPAAHQLHVLGSRSQVFASDSPPQSLLTPSRNSLNVDLYELGSTSVQQWPAATLARRDSLQKPGLEAPPRAHVAFRPDCPVPSRTNSFNSHQPRPGPPGKAEPSLPAPNTVTAVTAAHILHPVKSVRVLRPEPQTAVGPSHPAWVPAPAPAPAPAPAPAAEGLDAKEEHALALGGAGAFPLDVEYGGPDRRCPPPPYPKHLLLRSKSEQYDLDSLCAGMEQSLRAGPNEPEGGDKSRKSAKGDKGGKDKKQIQTSPVPVRKNSRDEEKRESRIKSYSPYAFKFFMEQHVENVIKTYQQKVNRRLQLEQEMAKAGLCEAEQEQMRKILYQKESNYNRLKRAKMDKSMFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDSLYFVMDYIPGGDMMSLLIRMEVFPEHLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHVRQDSMEPSDLWDDVSNCRCGDRLKTLEQRARKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEMLVGQPPFLAPTPTETQLKVINWENTLHIPAQVKLSPEARDLITKLCCSADHRLGRNGADDLKAHPFFSAIDFSSDIRKQPAPYVPTISHPMDTSNFDPVDEESPWNDASEGSTKAWDTLTSPNNKHPEHAFYEFTFRRFFDDNGYPFRCPKPSGAEASQAESSDLESSDLVDQTEGCQPVYV | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
5 | Phosphorylation | ---MRPKTFPATTYS ---CCCCCCCCCCCC | 37.22 | - | |
9 | Phosphorylation | RPKTFPATTYSGNSR CCCCCCCCCCCCCHH | 26.89 | - | |
10 | Phosphorylation | PKTFPATTYSGNSRQ CCCCCCCCCCCCHHH | 20.14 | - | |
11 | Phosphorylation | KTFPATTYSGNSRQR CCCCCCCCCCCHHHH | 15.38 | - | |
12 | Phosphorylation | TFPATTYSGNSRQRL CCCCCCCCCCHHHHH | 29.43 | - | |
43 | Phosphorylation | GLPAGPNSDTSLDAK CCCCCCCCCCCHHHH | 45.45 | 27251275 | |
45 | Phosphorylation | PAGPNSDTSLDAKVL CCCCCCCCCHHHHHH | 30.89 | 28555341 | |
50 | Ubiquitination | SDTSLDAKVLGSKDA CCCCHHHHHHCCCHH | 37.34 | - | |
55 | Ubiquitination | DAKVLGSKDATRQQQ HHHHHCCCHHHHHHH | 49.97 | - | |
55 | Acetylation | DAKVLGSKDATRQQQ HHHHHCCCHHHHHHH | 49.97 | 20167786 | |
58 | Phosphorylation | VLGSKDATRQQQQMR HHCCCHHHHHHHHHH | 38.86 | 26546556 | |
67 | Phosphorylation | QQQQMRATPKFGPYQ HHHHHHCCCCCCHHH | 19.35 | 26657352 | |
82 | Phosphorylation | KALREIRYSLLPFAN HHHHHHHHHHHHCCC | 14.88 | 22817900 | |
83 | Phosphorylation | ALREIRYSLLPFANE HHHHHHHHHHHCCCC | 17.37 | 10673337 | |
128 | Phosphorylation | LKQTGSRSIEAALEY HHHHCCHHHHHHHHH | 26.86 | 25002506 | |
135 | Phosphorylation | SIEAALEYISKMGYL HHHHHHHHHHHCCCC | 16.02 | 25002506 | |
154 | Ubiquitination | EQIVRVIKQTSPGKG HHHEEHHHCCCCCCC | 44.67 | - | |
168 | O-linked_Glycosylation | GLMPTPVTRRPSFEG CCCCCCCCCCCCCCC | 23.36 | 30379171 | |
172 | Phosphorylation | TPVTRRPSFEGTGDS CCCCCCCCCCCCCCC | 33.83 | 22817900 | |
253 | Phosphorylation | FPLQGAHYGRPHLLV CCCCCCCCCCCEEEC | 17.81 | 27642862 | |
272 | Phosphorylation | LGYGVQRSPSFQSKT CCCCCCCCCCCCCCC | 14.06 | 28555341 | |
274 | Phosphorylation | YGVQRSPSFQSKTPP CCCCCCCCCCCCCCC | 36.84 | 30576142 | |
277 | Phosphorylation | QRSPSFQSKTPPETG CCCCCCCCCCCCCCC | 36.16 | 26270265 | |
277 | O-linked_Glycosylation | QRSPSFQSKTPPETG CCCCCCCCCCCCCCC | 36.16 | 30379171 | |
278 | Ubiquitination | RSPSFQSKTPPETGG CCCCCCCCCCCCCCC | 55.02 | - | |
279 | Phosphorylation | SPSFQSKTPPETGGY CCCCCCCCCCCCCCC | 49.69 | 18669648 | |
283 | Phosphorylation | QSKTPPETGGYASLP CCCCCCCCCCCCCCC | 41.50 | 26270265 | |
286 | Phosphorylation | TPPETGGYASLPTKG CCCCCCCCCCCCCCC | 8.38 | 25159151 | |
288 | Phosphorylation | PETGGYASLPTKGQG CCCCCCCCCCCCCCC | 26.80 | 26270265 | |
291 | Phosphorylation | GGYASLPTKGQGGPP CCCCCCCCCCCCCCC | 53.77 | 26270265 | |
335 | Phosphorylation | LHVLGSRSQVFASDS HHCCCCCCCEECCCC | 32.18 | 24719451 | |
340 | O-linked_Glycosylation | SRSQVFASDSPPQSL CCCCEECCCCCCHHH | 27.44 | 30379171 | |
340 | Phosphorylation | SRSQVFASDSPPQSL CCCCEECCCCCCHHH | 27.44 | 25850435 | |
342 | O-linked_Glycosylation | SQVFASDSPPQSLLT CCEECCCCCCHHHCC | 35.66 | 30379171 | |
342 | Phosphorylation | SQVFASDSPPQSLLT CCEECCCCCCHHHCC | 35.66 | 25850435 | |
346 | O-linked_Glycosylation | ASDSPPQSLLTPSRN CCCCCCHHHCCCCCC | 30.99 | 30379171 | |
346 | Phosphorylation | ASDSPPQSLLTPSRN CCCCCCHHHCCCCCC | 30.99 | 25850435 | |
349 | Phosphorylation | SPPQSLLTPSRNSLN CCCHHHCCCCCCCCC | 25.22 | 27251275 | |
351 | Phosphorylation | PQSLLTPSRNSLNVD CHHHCCCCCCCCCEE | 38.57 | 27251275 | |
380 | Phosphorylation | ATLARRDSLQKPGLE HHHHHHHHCCCCCCC | 30.78 | 23401153 | |
406 | Phosphorylation | DCPVPSRTNSFNSHQ CCCCCCCCCCCCCCC | 39.28 | 23312004 | |
408 | Phosphorylation | PVPSRTNSFNSHQPR CCCCCCCCCCCCCCC | 25.78 | 25159151 | |
411 | Phosphorylation | SRTNSFNSHQPRPGP CCCCCCCCCCCCCCC | 22.84 | 23312004 | |
431 | O-linked_Glycosylation | PSLPAPNTVTAVTAA CCCCCCCCEEEEEHH | 20.41 | 30379171 | |
433 | O-linked_Glycosylation | LPAPNTVTAVTAAHI CCCCCCEEEEEHHHH | 17.24 | 30379171 | |
436 | O-linked_Glycosylation | PNTVTAVTAAHILHP CCCEEEEEHHHHHCC | 18.70 | 30379171 | |
446 | Phosphorylation | HILHPVKSVRVLRPE HHHCCCCEEEEECCC | 18.52 | 22817900 | |
526 | Phosphorylation | PKHLLLRSKSEQYDL CCCEECCCCCCCCCH | 40.27 | 30576142 | |
528 | Phosphorylation | HLLLRSKSEQYDLDS CEECCCCCCCCCHHH | 31.04 | 25849741 | |
531 | Phosphorylation | LRSKSEQYDLDSLCA CCCCCCCCCHHHHHH | 17.89 | 22115753 | |
535 | Phosphorylation | SEQYDLDSLCAGMEQ CCCCCHHHHHHHHHH | 32.42 | 22115753 | |
543 | Phosphorylation | LCAGMEQSLRAGPNE HHHHHHHHHHCCCCC | 13.40 | 28102081 | |
565 | Acetylation | RKSAKGDKGGKDKKQ CCCCCCCCCCCCHHH | 77.54 | 7709875 | |
570 | Acetylation | GDKGGKDKKQIQTSP CCCCCCCHHHCCCCC | 50.49 | 20167786 | |
571 | Acetylation | DKGGKDKKQIQTSPV CCCCCCHHHCCCCCC | 63.87 | 20167786 | |
575 | Phosphorylation | KDKKQIQTSPVPVRK CCHHHCCCCCCCCCC | 36.31 | 30266825 | |
576 | Phosphorylation | DKKQIQTSPVPVRKN CHHHCCCCCCCCCCC | 13.92 | 30266825 | |
598 | Phosphorylation | ESRIKSYSPYAFKFF HHHHHHHCHHHHHHH | 20.65 | 21815630 | |
616 | Phosphorylation | HVENVIKTYQQKVNR HHHHHHHHHHHHHHH | 18.55 | 26074081 | |
617 | Phosphorylation | VENVIKTYQQKVNRR HHHHHHHHHHHHHHH | 12.16 | 26074081 | |
620 | Ubiquitination | VIKTYQQKVNRRLQL HHHHHHHHHHHHHHH | 26.42 | - | |
651 | Ubiquitination | MRKILYQKESNYNRL HHHHHHHHHHCHHHH | 49.94 | - | |
690 | Phosphorylation | CLACKVDTHALYAMK HHHCCCCHHHHHHHH | 16.43 | - | |
697 | Ubiquitination | THALYAMKTLRKKDV HHHHHHHHHHHHHHC | 35.91 | - | |
793 | Ubiquitination | GFIHRDIKPDNILID CCCCCCCCCCCEEEE | 51.08 | - | |
827 | Ubiquitination | HNSKYYQKGSHVRQD CCCCCCCCCCCCCCC | 46.38 | - | |
829 | Phosphorylation | SKYYQKGSHVRQDSM CCCCCCCCCCCCCCC | 26.33 | 12853976 | |
835 | Phosphorylation | GSHVRQDSMEPSDLW CCCCCCCCCCHHHHH | 19.39 | 27251275 | |
839 | Phosphorylation | RQDSMEPSDLWDDVS CCCCCCHHHHHHHHH | 31.84 | 29449344 | |
872 | Phosphorylation | HQRCLAHSLVGTPNY HHHHHHHHCCCCCCC | 21.10 | 25850435 | |
876 | Phosphorylation | LAHSLVGTPNYIAPE HHHHCCCCCCCCCHH | 10.81 | 25850435 | |
939 | Ubiquitination | LHIPAQVKLSPEARD EECCCEEECCHHHHH | 31.03 | - | |
950 | Ubiquitination | EARDLITKLCCSADH HHHHHHHHHHHCCCC | 32.31 | - | |
968 | Ubiquitination | RNGADDLKAHPFFSA CCCHHHHHHCCCCCC | 52.20 | - | |
984 | Ubiquitination | DFSSDIRKQPAPYVP CCCCCHHHCCCCCCC | 62.05 | - | |
1024 | Phosphorylation | GSTKAWDTLTSPNNK CCCCHHHCCCCCCCC | 22.64 | 18669648 | |
1026 | Phosphorylation | TKAWDTLTSPNNKHP CCHHHCCCCCCCCCC | 44.20 | 18669648 | |
1027 | Phosphorylation | KAWDTLTSPNNKHPE CHHHCCCCCCCCCCC | 28.83 | 20363803 | |
1038 | Phosphorylation | KHPEHAFYEFTFRRF CCCCCCEEEEEEHHH | 15.77 | 23917254 | |
1041 | Phosphorylation | EHAFYEFTFRRFFDD CCCEEEEEEHHHCCC | 12.32 | 10871863 | |
1051 | Phosphorylation | RFFDDNGYPFRCPKP HHCCCCCCCCCCCCC | 12.88 | - | |
1064 | Phosphorylation | KPSGAEASQAESSDL CCCCCCHHHCCCCCC | 22.79 | 22210691 | |
1080 | Phosphorylation | SSDLVDQTEGCQPVY CCCCCCCCCCCEECC | 29.86 | 22210691 | |
1087 | Phosphorylation | TEGCQPVYV------ CCCCEECCC------ | 13.71 | 22210691 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
83 | S | Phosphorylation | Kinase | AURA | O14965 | PSP |
172 | S | Phosphorylation | Kinase | CHEK2 | O96017 | GPS |
380 | S | Phosphorylation | Kinase | AURKA | O14965 | GPS |
380 | S | Phosphorylation | Kinase | CHEK2 | O96017 | GPS |
408 | S | Phosphorylation | Kinase | CHEK1 | O14757 | GPS |
408 | S | Phosphorylation | Kinase | CHEK2 | O96017 | GPS |
446 | S | Phosphorylation | Kinase | CHEK2 | O96017 | GPS |
835 | S | Phosphorylation | Kinase | CHEK1 | O14757 | GPS |
835 | S | Phosphorylation | Kinase | LATS2 | Q9NRM7 | PSP |
- | K | Ubiquitination | E3 ubiquitin ligase | SIAH2 | O43255 | PMID:25438054 |
- | K | Ubiquitination | E3 ubiquitin ligase | DCAF1 | Q9Y4B6 | PMID:25026211 |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of LATS2_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of LATS2_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-279 AND SER-380, ANDMASS SPECTROMETRY. | |
"The centrosomal protein Lats2 is a phosphorylation target of Aurora-Akinase."; Toji S., Yabuta N., Hosomi T., Nishihara S., Kobayashi T., Suzuki S.,Tamai K., Nojima H.; Genes Cells 9:383-397(2004). Cited for: SUBCELLULAR LOCATION, INTERACTION WITH AURKA, MUTAGENESIS OF SER-83,AND PHOSPHORYLATION AT SER-83. | |
"Structure, expression, and chromosome mapping of LATS2, a mammalianhomologue of the Drosophila tumor suppressor gene lats/warts."; Yabuta N., Fujii T., Copeland N.G., Gilbert D.J., Jenkins N.A.,Nishiguchi H., Endo Y., Toji S., Tanaka H., Nishimune Y., Nojima H.; Genomics 63:263-270(2000). Cited for: NUCLEOTIDE SEQUENCE [MRNA] OF 42-1088, TISSUE SPECIFICITY, AND VARIANTVAL-324. |